Solventum (SOLV) Net Income towards Common Stockholders (2023 - 2026)
Solventum (SOLV) reported Net Income towards Common Stockholders of $13.0 million for Q1 2026, down 90.51% on a YoY basis from $137.0 million in Q1 2025, and down 79.37% quarter-over-quarter from $63.0 million in Q4 2025.
Solventum (SOLV) Net Income towards Common Stockholders (2023 - 2026) Analysis & Trends
Solventum has reported Net Income towards Common Stockholders for 4 years, with the latest figure at $13.0 million in Q1 2026.
- For the quarter ending Q1 2026, Net Income towards Common Stockholders fell 90.51% year-over-year to $13.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.4 billion (up 278.84% YoY), and the FY2025 full-year result was $1.6 billion, up 225.52% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at $13.0 million, down from $63.0 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $1.3 billion in Q3 2025, with the low at $13.0 million in Q1 2026.
- Historically, Net Income towards Common Stockholders has averaged $261.0 million across 4 years, with a median of $137.0 million in 2025.
- Annual changes were most pronounced in 2025 — Net Income towards Common Stockholders soared 937.7% — and 2026, when it plunged 90.51%.
- Solventum's Net Income towards Common Stockholders stood at $272.0 million in 2023, then tumbled by 88.97% to $30.0 million in 2024, then soared by 110.0% to $63.0 million in 2025, then tumbled by 79.37% to $13.0 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at $13.0 million (Q1 2026), $63.0 million (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 135.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 112.77 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | 72.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.00 Mn |
| Dec 31, 2025 | 63.00 Mn |
| Sep 30, 2025 | 1.27 Bn |
| Jun 30, 2025 | 90.00 Mn |
| Mar 31, 2025 | 137.00 Mn |
| Dec 31, 2024 | 30.00 Mn |
| Sep 30, 2024 | 122.00 Mn |
| Jun 30, 2024 | 89.00 Mn |
| Mar 31, 2024 | 237.00 Mn |
| Dec 31, 2023 | 272.00 Mn |
| Sep 30, 2023 | 460.00 Mn |
| Jun 30, 2023 | 321.00 Mn |
| Mar 31, 2023 | 293.00 Mn |